Clostridium GDH Rapid Test - Pack of 25 tests is an innovative immunochromatographic test designed for the qualitative detection of Clostridium difficile GDH in human stool samples. This test is essential for the rapid diagnosis of gastrointestinal infections caused by this opportunistic pathogen, which can proliferate following antibiotic therapy.

What is Clostridium difficile?

Clostridium difficile is an anaerobic bacterium that can cause serious intestinal infections. When the normal intestinal flora is altered, for example due to antibiotic treatment, this bacterium can grow and produce dangerous toxins. C. difficile infections can range from mild diarrhea to pseudomembranous colitis, and in some cases can lead to serious complications, including death.

Importance of the GDH Test

The test for Glutamate Dehydrogenase (GDH) is a highly effective method for detecting the proliferation of C. difficile, since all its forms produce high amounts of this enzyme. Detection of GDH in stool samples is a key indicator of the presence of C. difficile, but it is important to note that a positive result requires further tests to confirm the bacterium's toxicity.

Product Features

• Pack of 25 tests: Each package contains 25 rapid tests, ideal for clinical and diagnostic use.


• Ready to use: The test is easy to use and does not require complex preparation.


• Rapid results: Results are visible within 10 minutes, allowing timely diagnosis.


• Reliability: The colloidal gold membrane technology ensures accurate and reliable results.

How Does the Test Work?

The test is based on a membrane technology in which a nitrocellulose membrane is sensitized with an antibody specific to the GDH antigen of Clostridium difficile. The stool sample must be diluted in the provided extraction buffer. When the sample comes into contact with the strip, the soluble conjugate migrates by passive diffusion. If the sample contains GDH, a visible red line forms, confirming the presence of the bacterium.

Indications for Use

The test is indicated for:

• Diagnosis of Clostridium difficile infections in patients with gastrointestinal symptoms.


• Monitoring the proliferation of C. difficile in patients undergoing antibiotic therapy.


• Screening in clinical settings at high risk of C. difficile infections.

Conclusions

The Clostridium GDH Rapid Test is an essential tool for the early diagnosis of C. difficile infections. Thanks to its ease of use and rapid results, it is a valuable ally for healthcare professionals in managing gastrointestinal infections.